Literature DB >> 2285021

Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat.

S Desai, R Barton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2285021     DOI： 10.1007/bf02003220

Source DB:  PubMed          Journal:  Agents Actions        ISSN： 0065-4299


× No keyword cloud information.
  5 in total

1.  Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis.

Authors:  C F Brosnan; K Selmaj; C S Raine
Journal:  J Neuroimmunol       Date:  1988-04       Impact factor: 3.478

2.  Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the rat.

Authors:  S Desai; R Barton
Journal:  Agents Actions       Date:  1989-06

3.  An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats.

Authors:  D W Howat; N Chand; P Braquet; D A Willoughby
Journal:  Agents Actions       Date:  1989-06

4.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

Authors:  H J Schluesener; R A Sobel; C Linington; H L Weiner
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

5.  Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis.

Authors:  L L Perry; M E Barzaga
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422
  5 in total
  2 in total

1.  The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.

Authors:  Gijs Kooij; Jack van Horssen; Veera Venkata Ratnam Bandaru; Norman J Haughey; Helga E de Vries
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

2.  Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.

Authors:  Yasuyuki Kihara; Satoshi Ishii; Yoshihiro Kita; Akiko Toda; Atsuyoshi Shimada; Takao Shimizu
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.